Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Harmless virus levels may predict transplant complications

NCT ID NCT05836636

First seen May 01, 2026 · Last updated Jun 17, 2026 · Updated 8 times

Summary

This study looked at 172 kidney transplant recipients who were on stable anti-rejection medication for at least 3 months. Researchers measured levels of a common, harmless virus (Torque Teno Virus) in their blood to see if it could predict serious infections or organ rejection. The goal was to find a simple test that helps doctors personalize medication and improve long-term outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT; COMPLICATIONS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Singapore General Hospital

    Singapore, Singapore, 767972, Singapore

Conditions

The condition(s) this trial relates to.

renal infectious disease transplant rejection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.